Vertigo, a common clinical symptom, often presents diagnostic and therapeutic challenges to healthcare professionals. This article aims to provide a comprehensive clinical approach to unraveling vertigo.
Vertigo is primarily a symptom of vestibular dysfunction. It can be peripheral, originating from the inner ear, or central, sourced from the brainstem or cerebellum. Conditions such as Benign Paroxysmal Positional Vertigo (BPPV), Meniere's disease, and vestibular neuritis are common peripheral causes. Central causes include migraines, multiple sclerosis, and cerebrovascular diseases.
An accurate history is crucial in diagnosing vertigo. The onset, duration, frequency, and associated symptoms can provide valuable clues. Physical examination should include a thorough neurological and otologic assessment. Special tests like the Dix-Hallpike maneuver or the HINTS (Head-Impulse, Nystagmus, Test of Skew) can be performed to differentiate between peripheral and central causes.
Management of vertigo is multifaceted and depends on the underlying cause. For BPPV, canalith repositioning maneuvers have proven effective. Vestibular suppressants can provide symptomatic relief but are not recommended for long-term use due to potential side effects. In refractory cases, vestibular rehabilitation therapy or surgical interventions may be considered.
While not routinely indicated, imaging studies like MRI or CT scan can be useful in cases where a central cause is suspected. Early identification of potentially serious conditions such as stroke or tumor is critical for guiding management.
In conclusion, vertigo requires a comprehensive clinical approach for accurate diagnosis and management. An understanding of the pathophysiology, thorough clinical assessment, appropriate use of imaging, and tailored management strategies are key to unraveling this complex symptom and improving patient outcomes.
1.
Combo Therapy Boosts Early CML Response but Not Long Term
2.
PNH With Extravascular Hemolysis Approves Factor D Inhibitor.
3.
In a long-term comparison with adjuvant RT, salvage radiotherapy after prostateectomy is the most successful treatment.
4.
AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns
5.
Classifying childhood brain cancers by immune response may improve diagnostics and treatments
1.
Precision Oncology: Integrating Genomics and Data to Shape Cancer Care’s Future
2.
Decoding Hamartomas: Understanding Their Causes and Symptoms
3.
Understanding the Silent Threat: Unveiling Prostate Cancer Symptoms
4.
Battling Blood Cancers: Advances in HIV-Related Hematologic Malignancies in the ART Era
5.
Breaking Barriers: Innovative Approaches in Brain Tumor Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion
2.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
3.
Efficient Management of First line ALK-rearranged NSCLC
4.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation